Investing Profile

Karen Hong

InvestorVC
Partner at Novo Ventures
novoholdings.dkBoston, Massachusetts
Photo of Karen Hong, Partner at De Novo Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
University of California, Berkeley Network
501 CONNECTIONS
Massachusetts Institute of Technology Network
393 CONNECTIONS
cb
$100K - $5.0M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
OnCusp Therapeutics
Series AJan 2024$100M
$100M
Co-investors: Diyong Xu (OrbiMed), Chong Xu (F-Prime Capital Partners)
StrideBio
Series BMar 2021$82M
$98M
Co-investors: Shaan C. Gandhi (Longwood Fund), Jayson Punwani (Abingworth)
Cyteir Therapeutics
Series CFeb 2021$80M
Series BOct 2019$40M
$150M
Co-investors: Jean George (Advanced Technology Ventures), Racquel Bracken (Venrock), Derek DiRocco (RA Capital Management)
Agile Therapeutics
Post Ipo EquityFeb 2015$20M
Series CJul 2012$40M
Series BJun 2010$45M
$110M
Co-investors: Stacey Seltzer (Aisling Capital), Andrew Schiff (Aisling Capital)
Board Observer HotmailPresent
Board Director HotmailPresent
Board Director Clarus TherapeuticsPresent
Senior Investment Director, Takeda Ventures, Inc. TakedaPresent
Board Member Cyteir TherapeuticsPresent
Partner ProQuest InvestmentsPresent
Partner Novo VenturesPresent
Co-Founder HotmailPresent
University of California, Berkeley Bachelor's Degree B.S. Chemistry and B.A. Molecular Biology
Massachusetts Institute of Technology Ph.D. Molecular Biology